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Background: The Practice Management Committee (PMC) of the Pediatric Endocrine Society
(PES) conducted a survey of its membership in February/March, 2016 to assess the current
state of pediatric diabetes care delivery across multiple practice types in the United States.
Methods: The PES distributed an anonymous electronic survey (Survey Monkey) via email to
its membership and requested that only one survey be completed for each practice.
Results: Ninety-three unique entries from the US were entered into analysis. Care is predomi-
nantly delivered by multidisciplinary teams, based at academic institutions (65.6%), with >85%
of the provider types being physicians. Each 1.0 full time equivalent certified diabetes educa-
tors serves on average 367 diabetic youth. Fee-for-service remains the standard method of
reimbursement with 57% of practices reporting financial loss. Survey respondents identified
under-reimbursement as a major barrier to improving patient outcomes and lack of behavioral
health (BH) providers as a key gap in services provided.
Conclusions: Our survey reveals wide variation in all aspects of pediatric diabetes care delivery
in the United States. Pediatric Endocrinologists responding to the survey identified a lack of
resources and the current fee for service payment model as a major impediment to practice
and the lack of integrated BH staff as a key gap in service. The respondents strongly support
its organizations' involvement in the dissemination of standards for care delivery and advocacy
for a national payment model aligned with chronic diabetes care in the context of our emerging
value-based healthcare system.
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1 | INTRODUCTION
Type 1 diabetes, one of the most common chronic disorders of child-
hood, is increasing in incidence,1 affecting 1 in 300 children in the
United States by the age of 18.2 Type 2 diabetes, a condition virtually
unknown in children until the 1990s, is rising in prevalence as well,
requiring additional resources within pediatric endocrine practices.3
According to the International Society for Pediatric and Adoles-
cent Diabetes (ISPAD) 2014 Clinical Practice Consensus Guidelines
Compendium, the ultimate goal in diabetes care delivery is to “pro-
vide care that results in normal growth and development, high quality
of life, and lowest possible risk of acute and long-term complications.
This is best accomplished by helping children and families become
proficient in self-management, remain motivated throughout child-
hood and adolescence while mentoring children to develop into inde-
pendent, healthy adults”.4,5
Despite significant advances in diabetes therapeutic options and
technology in the past 2 decades, optimal care delivery models that
empower patients to benefit from these advances have not been
well-described or standardized nationwide. One well-recognized chal-
lenge to optimizing diabetes care delivery in the United States is the
progressive decline in traditional fee for service (FFS) payment,
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resulting in a greater need for institutional support. This decline has
impeded pediatric endocrinologists' ability to financially implement
their care teams and to maintain and evaluate optimal care models.
Under-resourced diabetes practices result in inadequate staffing and
lack of key professional team members whose role is to engage in
education and care coordination, while addressing social stressors
and behavioral health (BH) concerns.
Optimizing diabetes care requires that we expand our under-
standing of current care delivery models, their strengths and weak-
nesses, and the barriers to meeting patients' needs. To address this,
the Practice Management Committee (PMC) of the Pediatric Endo-
crine Society (PES) surveyed the membership to determine clinical
and financial information, including the average number of patients
with either type 1 or type 2 diabetes served in their practices, the
type of staff providing care, and how they are reimbursed. Most of
the questions focused on care delivery for patients with type 1 diabe-
tes, as they constitute the majority in most diabetes practices. The
membership was also asked if they felt their current staffing levels
and reimbursement enabled them to achieve the ISPAD goals. In
addition, the survey authors were interested in knowing to what
extent survey responders desire PES to engage on their behalf in
advocacy efforts toward healthcare policy makers and payers.
2 | METHODS
An anonymous, self-report survey of pediatric diabetes practices was
formulated on Survey Monkey by members of the PMC and distributed
by PES to its members from February to March, 2016. Although sent to
all members, survey instructions requested that the senior member (divi-
sion chief or head of diabetes section) complete the survey as both the
scope and complexity of the survey (>70 complex questions) warranted
practice-wide vs individual provider participation. The project was
reviewed by the Research Advisory Council of the PES, who determined
it was a quality improvement rather than a research initiative and did
not require IRB approval. Survey questions were grouped into 4 sections
addressing the following topics: (1) practice settings and staffing charac-
teristics; (2) behavioral/mental health care; (3) pediatric endocrinologists'
satisfaction with and concerns about current state of practice; and
(4) patient outcome data. Data requested in this last section was similar
to data requested by US News and World Report for its Best Children's
Hospital rankings, and thus the data was reported only for those institu-
tions who participated in this survey. Participants were allowed to report
the data using the databases of their choice, and we were not able to
independently verify the accuracy of the submitted answers. Respon-
dents were permitted to skip questions, so we reported the number of
respondents for each item. Responses were transferred to SAS Enter-
prise version 6.1 for further statistical analyses. Non-structured informa-
tion was categorized into themes and reported as such.
3 | RESULTS
Surveys were sent out to all the membership of the PES. There were
101 responses from the US. Thirteen responses (12.9%) were from
the same practices with identical internet protocol addresses: 5 were
double entries, and 1 was a triple entry. The final dataset included
93 unique entries. Because respondents were not required to
respond to each item, there were substantial missing values; hence,
the number of responding participants is stated for each item. In
total, data regarding the care of 73 170 pediatric patients with type
1 diabetes and 10 440 patients with type 2 diabetes were reported.
There is currently no reliable database that would specify the number
of Pediatric Endocrinology practices in the US, but we estimate that
our survey covered practices that take care of approximately 30% to
40% of all youth with diabetes in the US.1
4 | PRACTICE TYPE AND KEY
CHARACTERISTICS
The majority of responders were academic medical centers (65%),
accounting for a total of 66 120 patients (Table 1). The majority of
respondents (85%) were hospital based, with few (12%) private prac-
tice respondents. Primary providers in most practices were
physicians—86.0% of 57 academic centers, 83.3% of 18 non-academic
centers, and 100% of 10 private practices. Advanced practice pro-
viders (Nurse Practitioners and Physician Assistants) accounted for a
much smaller fraction of primary providers.
Characteristics of responding academic, non-academic and pri-
vate practices are displayed in Table 1 (practice size) and Table 2
(patient load/staff ratio).
5 | NEW-ONSET CARE
The average (SD) number of newly diagnosed type 1 and 2 diabetes
patients per year was 97.4  84.2 (n = 89) and 22.3  25.4 (n = 82),
respectively.
Initial education of newly diagnosed patients with T1D was pre-
dominantly provided in the inpatient setting in 71.0% of 89 respond-
ing centers. The duration of new patient education was difficult to
determine because respondents described a wide variety of practices,
often reporting combining inpatient- and outpatient-administered
modules. Diabetes education was provided by certified diabetes edu-
cator (CDE) employed by the clinics in 72% of responding institutions
and by hospital inpatient nursing staff alone in 11.8%. The remaining
16.2% of practices reported using different types of resources. Group
sessions were used by less than half respondents (48%) during their
education process, either at onset or shortly after the onset of type
1 diabetes. Of 91 respondents, 55.0% reported that their practices
did not have a specific, separate education process for the initial edu-
cation of type 2 diabetes patients.
6 | ESTABLISHED AMBULATORY CARE
Patients time slots scheduled with physicians varied, with 30 minutes
per patient the most common (60%), while 15 to 20 minutes slots
were reported by 22.6% of physicians and >30 minutes by 17.2%.
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Advanced care providers had more time allotted for appointments;
among the 64 respondents, 42.2% reported having 30 minutes and
46.9% reported having 45 minutes or longer. Survey responders
found it difficult to quantify visit time with CDEs, who often do not
schedule free standing appointments, but rather see patients together
with other providers.
The average (SD) time that a patient with diabetes spends in a
follow-up appointment, from check-in to check-out, was estimated to
be 67.7  27.8 minutes in the main clinic by 89 respondents and
57.2  20.8 minutes in satellite clinics by 54 respondents. Seventy-
eight percent of 91 responding practices reported utilizing care
coordination, and 70.7% of 65 practices reported having specific
interventions for patients with socio-economic status challenges/
poor adherence and services to aid with transition to adult care. Very
few practices (18.9% of 90 reporting) reported utilizing videoconfer-
ence telemedicine visits, and 35.9% of 89 practices reported having a
patient/family advisory board.
7 | ADHERENCE TO STANDARDS OF CARE
Of the 47 reporting centers, practices regarding adherence to stan-
dards of care showed that 56.4% of type 1 diabetes patients had 4 or
more visits per year, as recommended by ADA, and 86.8% of primary
diabetes patients (including both type 1 and 2) had a face-to-face
visit with a CDE in the preceding year. Of the 46 reporting practices,
71.3% and 46.4% of patients had face-to-face visits with a dietitian
and a mental health specialist, respectively, in the preceding year.
Median A1c value in patients with commercial insurance was
8.3  0.22% (68 nmol/mol) in academic medical centers (n = 25),
8.41  0.27% (68 nmol/mol) in non-academic centers (n = 8) and
7.75  0.4% (61 nmol/mol) in private practices (n = 4). In patients
with Medicaid, those values were 8.80  0.45% (73 nmol/mol) in
academic medical centers (n = 27), 8.98  0.47% (75 nmol/mol) in
non-academic centers (n = 8) and 8.18  0.72% (66 nmol/mol) in pri-
vate practices (n = 4). Among 48 reporting practices, 93.1% of eligible
type 1 diabetes patients had thyroid tests performed in the past
2 years. Of type 1 and 2 diabetes patients >10 years, 89.7% had lipid
screen performed in the past 5 years; among those who additionally
had a duration of diabetes >5 years, 85.1% had urine microalbumin
screen in the past year and 58.7% had retinal exam done in the pre-
ceding year. Patients of private practices (n = 8) tended to be more
adherent to standards of screening; however, the number of private
practices respondents was too small to draw conclusions about
importance of this finding.
8 | REIMBURSEMENT
Fee-for-service was the main method of reimbursement as was
reported by 82.0% of 89 responding practices. Table 3 illustrates the
billing practices for support services.
TABLE 1 Descriptive statistics for numbers of type 1 and type 2 diabetes patients by region and provider type
Total Academic Non-academic Private
Region Diabetes n M SD n M n M n M
Total Total 90 929 723 58 1140 19 664 11 374
Type 1 813 661 1002 571 325
Type 2 116 112 138 92 49
Midwest Total 19 1126 729 13 1398 4 677 2 255
Type 1 1027 675 1267 641 243
Type 2 99 82 131 36 13
Northeast Total 22 712 446 17 733 3 780 2 423
Type 1 611 390 644 564 400
Type 2 100 114 89 215 23
South Total 29 931 677 18 1036 7 887 3 497
Type 1 770 585 847 780 367
Type 2 161 121 189 107 130
West Total 20 978 977 10 1682 5 271 4 318
Type 1 892 916 1542 228 298
Type 2 86 108 140 43 20
TABLE 2 Number of patients with T1D per provider type
Total Academic Non-academic Private
n M SD n M SD n M SD n M SD
Type 1 patients per…
Social worker 61 2032 2831 48 2246 3150 12 1255 614 1 1083
Dietitian 75 750 545 54 824 581 16 514 344 4 761 587
Psychologist 38 3455 3549 33 3601 3540 3 3827 4805 1 500
Educators 83 367 385 55 395 447 19 274 217 7 453 166
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Eighty-nine percent of 84 respondents reported that their prac-
tices received no reimbursement for non-face-to-face services. Of
86 practices, 15.1% reported financial profit from providing diabetes
services, 57.0% reported loss and 27.9% reported not having access
to the information. Of 13 profit-reporting practices, 53.8% were pri-
vate practices, 15.4% were academic and 23.1% were non-academic
practices. Thus the rate of taking care of patients with diabetes for a
loss is a staggering 96.6% in a academic centers and 84.3% in non-
academic, hospital based practices.
9 | BH SERVICES
Of 87 respondents, 56.3% reported having one or more BH specialists
integrated in their team, 26.4% reported having access to those services
within their institution and 17.2% reported no access to BH services.
Of 81 respondents, 40.7% indicated that BH specialists in their practice
see all new patients, and 43.5% of 85 respondents reported screening
type 1 diabetes patients for mental health problems using a validated
screening tool. Four barriers to mental health services were reported to
be either significant or very significant barriers by most respondents:
lack of insurance coverage by 76.5% of 81 respondents, lack of BH pro-
viders in the area by 61.4% of 83 respondents, lack of BH providers
trained in diabetes in 69.5% of 82 respondents, and lack of institutional
support for multidisciplinary approach by 59.3% of 81 respondents.
Eighteen (23.7%) of 76 practices reported having BH specialists rou-
tinely see all clinic patients for prevention and guidance, with the rest
reporting that those services are offered to psychologically challenged
patients only. Of 65 participants reporting how BH services were reim-
bursed, 55.4% indicated the clinic covering the costs, 58.5% indicated
FFS, 6.2% indicated grant, and 6.2% indicated foundation support.
10 | PROVIDER SATISFACTION AND
CONCERNS
Seventy-six (89.4%) of 85 responders indicated that they were very
or somewhat satisfied with the duration and quality of care provided
to their patients with type 1 diabetes at diagnosis. Among those
9 respondents who reported not being satisfied, 88.9% indicated that
they would prefer more education to be available to the patients
after the initial diagnosis on the outpatient basis and 87.5% of
8 responders would like to see a more consistent process of educa-
tion, provided by specialized providers, with CDE qualification. Sixty-
one (71.7%) of 85 responders were satisfied with the time allotted
for follow-up clinic visits and the current composition of their team.
Table 4 illustrates major areas of concern. When asked for improve-
ment suggestions, the greatest needs were expressed for BH support
and higher reimbursement, so the staff can spend the time they need
with the patient.
Regarding the reimbursement climate, 59.8% of 82 responders
indicated that they are either very or somewhat dissatisfied with the
current FFS model.
Last, 78.8% of 85 respondents thought it was somewhat or very
important to create staffing guidelines for care of children with type
1 diabetes, that would be recognized as best practice and >90% of
85 respondents indicated that PES should take the lead in establish-
ing the standards.
11 | DISCUSSION
Our survey captured quantitative and qualitative data from all forms
of clinical practices caring for over 80 000 children with diabetes.
Based on the SEARCH study data from 2010, 179 387 US youth
were estimated to have the diagnosis type 1 diabetes and 22 820 of
the type 2 diabetes.1 We found that pediatric diabetes care facilities
in the US are concentrated in academic health centers and hospital
based practices. It is not clear if the lack of private practice centers
reporting is due to the fact that many do not care for patients with
diabetes or that they did not respond to the survey. Physicians con-
stitute the majority of primary providers across all practice settings
with advanced practice providers significantly less frequently
employed in that role. Consistent with their central role in diabetes
care and education, we found that CDEs are the most common non-
physician diabetes team professional employed, with an approximate
ratio of 1 full-time educator per 367 children in the practice. Regis-
tered dietitians (RDs) are the next most commonly employed non-
MD professional, with an approximate ratio of 1 RD for every 2 CDEs,
although it was not possible to determine to what extent the RDs
were utilized in a combined CDE/RD role. BH providers are less com-
monly employed within the care team. Although no correlations were
observed between staffing ratios and A1c, we recommend caution in
accepting this negative finding, due to the insufficient number of
practices reporting A1c values to our survey. Future prospective
studies are needed to ascertain which provider types and interven-
tions result in the best outcomes. Registries, similar to one used for
patients with cystic fibrosis would allow for more consistent data col-
lection and a more accurate analysis.
Our A1c dataset is consistent with that of the T1D Exchange
(5) and demonstrates that over 50% of children with diabetes do not
achieve the ADA published A1c target of <7.5%. In addition, as has
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82 43% 57% 29 90% 10%
Drop-by services 79 11% 89% 7 100% 0%
Services
Social work 83 12% 88% 5 80% 20%
Nutrition 85 71% 29% 53 92% 8%
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been reported for other pediatric chronic conditions, Medicaid-insured
patients experience worse outcomes, irrespective of practice type.
A 30 minute visit time with the team professional was deemed
to be adequate by a majority of providers, but the length of visit
might be more dependent to the institutional constraints, rather than
physicians' preference, so this information should be interpreted with
caution. Patient-reported outcomes (PROs) were not captured by our
survey.
Only 56% of patients met the standard of care for quarterly visits,
despite the fact that missed visits are associated with poor glycemic
control and preventable episodes of diabetic ketoacidosis.6 This find-
ing underscores the need to explore the causes for missed visits and
to guide potential interventions such as telehealth visits, flexible
hours, and employing BH and social work (SW) as well as care coordi-
nators to ensure that high-risk patients keep their appointments.
Meeting the needs of the most vulnerable patients and families
requires access to care coordinators trained on linking patients and
families to available community-based and BH services. Typically it is
the role of SW, however only 56.3% of practices (primarily academic
institutions) have those team members available.
Similarly, the implementation of a staged transition to adult care
is not standardized, nor is the adoption of a specific new-onset pro-
cess for type 2 diabetes patients whose medical and behavioral-social
needs differ from the typical type 1 diabetes patient.
It is our opinion that the observed variability in staffing levels
and other aspects of care delivery likely reflects leadership decisions,
patient demographics, local culture, and financial resources. It is pos-
sible that this variability could be reduced if there was a national con-
sensus statement establishing best practices for team composition,
staffing ratios and core components of care delivery. We attribute
the fact that 89% of the responders express satisfaction with the
quality of care provided, while 90% recognize the need for additional
BH support, to “cognitive dissonance” related to a “learned helpless-
ness” among under-resourced pediatric endocrinologists within their
organizations.7
Slightly more than half of surveyed practices had a BH specialist
integrated within their team, and only 23.7% reported those special-
ists providing preventive care and guidance within the diabetes clinic,
indicating an understaffed and largely “reactive” model of BH inter-
vention. The prevalence of psychological issues in diabetic youth is
significantly higher than those without diabetes and is associated
with decreased self-care, higher A1C, poor diabetes outcomes, and
increased health costs.8,9 Psychosocial screening is recommended as
a standard part of initial and ongoing care to identify families at risk
for early emerging complications and non-adherence.10 Systematic
reviews and meta-analyses found that the most effective interven-
tions were those delivered to the family or groups of families, leading
to improved health outcomes and lower cost of care.11–13 Despite
this evidence, cost and low reimbursement are expressed by most
respondents as the main barriers to integrating sufficient BH services
within diabetes care teams (Table 4).
Survey results indicate that 71% of diabetes care teams admit
their new-onset patients for education, despite the fact that ambula-
tory new-onset care for metabolically stable patients is equally effec-
tive and dramatically cheaper.14,15 The reality is that high-cost
inpatient new-onset care will predominate until new payment models
are in place that rewards healthcare entities to transition new-onset
care to the outpatient setting.16,17
Although FFS represents a substantial portion of care delivered
by diabetes teams nationwide, it does not cover laborious non-face-
to-face care18. At least 57% of practices report negative margins on
providing diabetes care which validates previous analyses by The Dia-
betes Working Group,19 and Melzer et al.20 We speculate that this is
due to the low rate of billing for diabetes education, clinical behav-
ioral therapy and social work services in the current system (Table 3)
and by the huge amount of uncompensated time spent by CDEs on
phone triage, insurance paperwork and education.
Most of the survey responders consider change in reimburse-
ment model a high priority (Table 4). Although local innovation has
established a proof-of-concept for a longitudinal bundled payment
model for youth with T1D in 1 pediatric institution, it became unsus-
tainable in the face of current health reform trends that are shifting
more of the cost burden to families.21 As we adopt population health
strategies and demonstrate the value diabetes care teams provide,
we will be able to join the growing ranks of provider organizations
that are implementing and evaluating value-based care and payment
models. Until then, optimization of FFS reimbursement for RDs,
CDEs, SWs and psychologists can partially offset the costs of care for
youth with diabetes.
At the same time we aim for financial sustainability, we need to
find ways to deliver quality care at lower costs. The introduction of
new efficiencies and technology into care delivery will become
increasingly important. Telemedicine is a rapidly expanding mode of
care delivery, shown to increase patient engagement and expand
touch points with their care team. A recent study by Wood
et al demonstrated an improvement in ADA standard adherence with
telemedicine visits.21 Low (19%) adoption of telemedicine, indicated
TABLE 4 Likert ratings for staffing and payment questions
%
Question n 1 2 3 4 5
Rate your agreement with the following Statementsa
Need more MD providers 83 8% 20% 28% 13% 30%
Need more non-MD providers
(APN/PA)
80 14% 14% 36% 18% 19%
Need more RN/CDE support 84 4% 8% 15% 27% 45%
Need more dietitian support 83 4% 5% 23% 35% 34%
Need more mental health
support
84 1% 1% 10% 25% 63%
Need more reimbursement 83 5% 0% 8% 24% 63%
Rate the importance of each of the followingb
Increase fee via value-added
payment system
77 1% 1% 17% 35% 45%
Availability of more coding
options
77 8% 5% 25% 32% 30%
Reimbursement for non-face-to-
face services
79 0% 0% 3% 19% 78%
Bundled payments/capitation 73 5% 4% 36% 32% 23%
a 1, strongly disagree; 2, disagree; 3, neutral; 4, agree; 5, strongly agree.
b 1, very unimportant; 2, somewhat unimportant; 3, neither important nor
unimportant; 4, somewhat important; 5, very important.
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by our survey respondents represents another strategy to pursue, as
more and more states and payers reimburse direct to patient remote
visits. Based on our survey data and current healthcare trends, future
areas of focus might also include how best to integrate the patient
and family perspective into the care team, the development and vali-
dation of PROs, and the analysis of the key aspects of care delivery,
technology, and payment models that optimize key diabetes out-
comes across diverse healthcare settings.22
Succeeding in our rapidly changing and disruptive healthcare
environment calls upon organizations and advocacy groups to partner
together. PES recently formed a Special Interest Group for pediatric
diabetes to represent the views of its membership, advocate on their
behalf, and serve as a PES representative in relevant joint initiatives.
Similarly, the T1D Exchange and the Juvenile Diabetes Research
Foundation have partnered together to develop and disseminate a
set of standardized diabetes outcome measures beyond A1c, to be
used as common language to assess outcomes and conduct
research.23
In summary, our survey results provides information not recently
or previously gathered on 93 US diabetes practices and demonstrates
a wide variability in care delivery and team composition across prac-
tices. The greatest perceived barrier among respondents to improving
care is the lack of financial resources and the greatest care gap is BH.
A major limitation to interpreting the results of our survey is that
responders were allowed to respond to questions of their choosing,
and that the data reported could not be independently verified. This
certainly brings up a concern for observational bias, which we
acknowledge. Despite these limitations, the consistent themes that
emerged resonate with the collective experience of front-line practic-
ing pediatric endocrinologists and lead the authors to conclude that
the survey findings represent the status of pediatric diabetes care
teams in the US.
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